Predicted to enable enzyme binding activity; signaling adaptor activity; and signaling receptor binding activity. Predicted to be involved in B cell activation; negative regulation of B cell activation; and negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction. Predicted to act upstream of or within negative regulation of gene expression; positive regulation of MAPK cascade; and response to bacterium. Predicted to be located in perinuclear region of cytoplasm. Human ortholog(s) of this gene implicated in autoimmune thyroiditis; psoriasis; systemic lupus erythematosus; systemic scleroderma (multiple); and type 1 diabetes mellitus. Orthologous to human BANK1 (B cell scaffold protein with ankyrin repeats 1); INTERACTS WITH acetamide; alpha-Zearalanol; amphetamine.
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...